This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2006 Nov 1;12(21):6323-5.

doi: 10.1158/1078-0432.CCR-06-1707.

Is the type I insulin-like growth factor receptor a therapeutic target in endometrial cancer?

Hua Zhang¹, Douglas Yee

Affiliations

PMID: 17085640
DOI: 10.1158/1078-0432.CCR-06-1707

Review

Is the type I insulin-like growth factor receptor a therapeutic target in endometrial cancer?

Hua Zhang et al. Clin Cancer Res. 2006.

. 2006 Nov 1;12(21):6323-5.

doi: 10.1158/1078-0432.CCR-06-1707.

Authors

Hua Zhang¹, Douglas Yee

Affiliation

¹ University of Minnesota Cancer Center, Minneapolis, Minnesota 55455, USA.

PMID: 17085640
DOI: 10.1158/1078-0432.CCR-06-1707

No abstract available

PubMed Disclaimer

Comment on

Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium.
McCampbell AS, Broaddus RR, Loose DS, Davies PJ. McCampbell AS, et al. Clin Cancer Res. 2006 Nov 1;12(21):6373-8. doi: 10.1158/1078-0432.CCR-06-0912. Clin Cancer Res. 2006. PMID: 17085648

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems